Olympus (OTCMKTS:OLYMY) Stock Price Down 1.2% – What’s Next?

Shares of Olympus Co. (OTCMKTS:OLYMY) traded down 1.2% on Thursday . The stock traded as low as $10.70 and last traded at $10.74. Approximately 46,373 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 109,258 shares. The stock had previously closed at $10.87.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group cut shares of Olympus from a “buy” rating to a “neutral” rating in a report on Monday, June 15th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Olympus presently has an average rating of “Hold”.

Olympus Stock Performance

The company has a 50 day simple moving average of $10.82 and a 200 day simple moving average of $10.76.

Olympus Company Profile

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.